NIHR Maudsley BRC Blog

Our latest news and events

Novavax confirms vaccine provides 100% protection against severe COVID-19

Final analysis of UK Phase 3 trials of Novavax's COVID-19 vaccine reveals it provides 100% protection against severe COVID-19.

By NIHR Wellcome King's Clinical Research Facility at 16 Mar 2021
Read more >

Londoner proud to play his part in COVID-19 fightback by taking part in vaccine trial

A 30-year-old man has spoken about his pride in aiding the national fightback against COVID-19 by taking part in vaccine research in south London.

By NIHR Wellcome King's Clinical Research Facility at 26 Feb 2021
Read more >

Novavax trial reveals 89.3% effectiveness in preventing COVID-19

Interim analysis of study shows that the NIHR-supported Novavax COVID-19 vaccine is 89.3% effective at preventing COVID-19, including effectiveness against the new variants of concern.

By NIHR Wellcome King's Clinical Research Facility at 29 Jan 2021
Read more >

SIREN study finds past COVID-19 infection provides some immunity for at least five months

The first report from Public Health England's national SIREN study, supported at King's College Hospital by the King's CRF, has found that past COVD-19 infection provides 83% immunity for at least five months. However, some people may still carry the virus and transmit to other people.

By NIHR Wellcome King's Clinical Research Facility at 19 Jan 2021
Read more >

New swabbing pod open at King's CRF

A new swabbing pod has been installed next to the Clinical Trials Facility at King’s College Hospital so that outpatients and trial participants who are symptomatic or have tested positive for COVID-19 can continue to receive treatment or attend follow-up appointments.

By NIHR Wellcome King's Clinical Research Facility at 8 Dec 2020
Read more >